PE Ratio
16.67
-0.09-0.54%
Thu, 20 Feb 2025 22:03:20 GMT
Summary
- As of February 21, 2025, HALO price to earnings ratio is 16.67, with a fall of -0.09 (-0.54%) during the most recent trading day.
- Over the past year, HALO PE ratio has dropped by -1.10 (-6.19%).
- HALO PE ratio is now -93.89% below its all-time high of 272.63.
Performance
HALO PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PE Ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
HALO PE Ratio Trends
| PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -0.5% | -0.5% | +13.6% | +7.2% |
| 1 m1 month | +3.5% | +3.5% | - | - |
| 3 m3 months | +9.0% | +23.8% | +13.6% | +7.2% |
| 6 m6 months | -29.5% | -6.3% | - | - |
| ytdytd | +18.8% | +18.8% | - | - |
| 1 y1 year | -6.2% | +52.5% | +62.6% | +22.4% |
| 5 y5 years | - | +166.1% | +82.5% | +30.1% |
HALO PE Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.1% | 15.71 | +6.1% | |
| 3 m | 3-month | 17.20 | -3.1% | 13.88 | +20.1% |
| 6 m | 6-month | 25.19 | -33.8% | 13.88 | +20.1% |
| 1 y | 1-year | 25.19 | -33.8% | 13.88 | +20.1% |
| 3 y | 3-year | 40.05 | -58.4% | 11.90 | +40.1% |
| 5 y | 5-year | 272.63 | -93.9% | 11.41 | +46.1% |
| alltime | all time | 272.63 | -93.9% | 11.41 | +46.1% |
Halozyme Therapeutics PE Ratio History
| Date | Value |
|---|---|
| 2025 | 16.67(+18.8%) |
| 2024 | 14.03(-19.9%) |
| 2023 | 17.52(-55.3%) |
| Date | Value |
|---|---|
| 2022 | 39.17(+167.9%) |
| 2021 | 14.62(-69.2%) |
| 2020 | 47.46(-11.0%) |
| 2017 | 53.32 |
FAQ
- What is Halozyme Therapeutics price to earnings ratio?
- What is the all time high PE ratio for Halozyme Therapeutics?
- What is HALO price to earnings ratio year-to-date change?
- What is Halozyme Therapeutics PE ratio year-on-year change?
What is Halozyme Therapeutics price to earnings ratio?
The current PE ratio of HALO is 16.67
What is the all time high PE ratio for Halozyme Therapeutics?
Halozyme Therapeutics all-time high price to earnings ratio is 272.63
What is HALO price to earnings ratio year-to-date change?
Halozyme Therapeutics price to earnings ratio has changed by +2.64 (+18.82%) since the beginning of the year
What is Halozyme Therapeutics PE ratio year-on-year change?
Over the past year, HALO price to earnings ratio has changed by -1.10 (-6.19%)